241 related articles for article (PubMed ID: 28499959)
1. Impact of initial empirical antifungal agents on the outcome of critically ill patients with invasive candidiasis: analysis of the China-SCAN study.
Cui N; Wang H; Qiu H; Li R; Liu D
Int J Antimicrob Agents; 2017 Jul; 50(1):74-80. PubMed ID: 28499959
[TBL] [Abstract][Full Text] [Related]
2. Initial therapeutic strategy of invasive candidiasis for intensive care unit patients: a retrospective analysis from the China-SCAN study.
Cui N; Wang H; Su L; Qiu H; Li R; Liu D;
BMC Infect Dis; 2017 Jan; 17(1):93. PubMed ID: 28114898
[TBL] [Abstract][Full Text] [Related]
3. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
Bailly S; Bouadma L; Azoulay E; Orgeas MG; Adrie C; Souweine B; Schwebel C; Maubon D; Hamidfar-Roy R; Darmon M; Wolff M; Cornet M; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(10):1139-46. PubMed ID: 25780856
[TBL] [Abstract][Full Text] [Related]
4. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF;
J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387
[TBL] [Abstract][Full Text] [Related]
5. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Bailly S; Leroy O; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Azoulay E; Timsit JF
Intensive Care Med; 2015 Nov; 41(11):1931-40. PubMed ID: 26370688
[TBL] [Abstract][Full Text] [Related]
6. Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.
van der Geest PJ; Rijnders BJ; Vonk AG; Groeneveld AB
Mycoses; 2016 Mar; 59(3):179-85. PubMed ID: 26707572
[TBL] [Abstract][Full Text] [Related]
7. Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.
Garnacho-Montero J; Díaz-Martín A; Cantón-Bulnes L; Ramírez P; Sierra R; Arias-Verdú D; Rodríguez-Delgado M; Loza-Vázquez A; Rodriguez-Gomez J; Gordón M; Estella Á; García-Garmendia JL
Crit Care Med; 2018 Mar; 46(3):384-393. PubMed ID: 29189345
[TBL] [Abstract][Full Text] [Related]
8. Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.
Reboli AC; Rotstein C; Kett DH; Maschio M; Cartier S; Chambers R; Tarallo M
Pharmacoeconomics; 2011 Aug; 29(8):705-17. PubMed ID: 21591820
[TBL] [Abstract][Full Text] [Related]
9. Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU.
Bruyère R; Quenot JP; Prin S; Dalle F; Vigneron C; Aho S; Leon C; Charles PE
BMC Infect Dis; 2014 Jul; 14():385. PubMed ID: 25015848
[TBL] [Abstract][Full Text] [Related]
10. Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis.
Keane S; Geoghegan P; Povoa P; Nseir S; Rodriguez A; Martin-Loeches I
Expert Rev Anti Infect Ther; 2018 Nov; 16(11):839-847. PubMed ID: 30257597
[TBL] [Abstract][Full Text] [Related]
11. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?
Wang Y; McGuire TM; Hollingworth SA; Dong Y; Van Driel ML
Int J Infect Dis; 2019 Dec; 89():137-145. PubMed ID: 31639522
[TBL] [Abstract][Full Text] [Related]
12. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.
Kett DH; Shorr AF; Reboli AC; Reisman AL; Biswas P; Schlamm HT
Crit Care; 2011; 15(5):R253. PubMed ID: 22026929
[TBL] [Abstract][Full Text] [Related]
13. Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Ruhnke M; Paiva JA; Meersseman W; Pachl J; Grigoras I; Sganga G; Menichetti F; Montravers P; Auzinger G; Dimopoulos G; Borges Sá M; Miller PJ; Marček T; Kantecki M
Clin Microbiol Infect; 2012 Jul; 18(7):680-7. PubMed ID: 22404732
[TBL] [Abstract][Full Text] [Related]
14. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis.
Bienvenu AL; Pradat P; Guerin C; Aubrun F; Fellahi JL; Friggeri A; Guichon C; Hernu R; Menotti J; Monard C; Paulus S; Rimmele T; Piriou V; Chidiac C; Argaud L; Leboucher G
Int J Infect Dis; 2020 Apr; 93():15-21. PubMed ID: 31982622
[TBL] [Abstract][Full Text] [Related]
16. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
17. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
[TBL] [Abstract][Full Text] [Related]
18. Predictors of choice of initial antifungal treatment in intraabdominal candidiasis.
Lagunes L; Borgatta B; Martín-Gomez MT; Rey-Pérez A; Antonelli M; Righi E; Merelli M; Brugnaro P; Dimopoulos G; Garnacho-Montero J; Colombo AL; Luzzati R; Menichetti F; Muñoz P; Nucci M; Scotton G; Viscoli C; Tumbarello M; Bassetti M; Rello J;
Clin Microbiol Infect; 2016 Aug; 22(8):719-24. PubMed ID: 27432766
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiologial profile of invasive candidiasis in intensive care units at a university hospital].
Ajenjo H MC; Aquevedo S A; Guzmán D AM; Poggi M H; Calvo A M; Castillo V C; León C E; Andresen H M; Labarca L J
Rev Chilena Infectol; 2011 Apr; 28(2):118-22. PubMed ID: 21720690
[TBL] [Abstract][Full Text] [Related]
20. [Antifungal treatment for suspected or proved candidiasis in the critically ill].
Massanet P; Jung B; Molinari N; Villiet M; Moulaire V; Roch-Torreilles I; Jaber S; Reynes J; Corne P
Ann Fr Anesth Reanim; 2014 Apr; 33(4):232-9. PubMed ID: 24684836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
